Dry Eye in Dogs (Keratoconjunctivitis Sicca, KCS)
- Occurrence: common
- Location of disease: Head/Neck
When to visit the vet?
Non-urgent see a veterinarian within 2–3 days
If the condition worsens / symptoms persist, consult a veterinarian.
Definition
Keratoconjunctivitis sicca (KCS), also known as dry eye syndrome, is a chronic condition in dogs characterized by insufficient tear production. This reduced tear production leads to a dry, irritated, and inflamed ocular surface.
BASICS/CAUSES:
Tear fluid plays an essential role in maintaining the health of the ocular surface. It consists of a mixture of water, mucus, and lipids that together moisturize, protect, and nourish the cornea and conjunctiva. Without sufficient tear fluid, dirt particles and microorganisms can more easily damage the ocular surface, which can lead to inflammatory conditions and infection.
One of the most common causes of KCS in dogs is an autoimmune disease in which the immune system mistakenly attacks and destroys the tear-producing glands. This form of KCS is often referred to as immune-mediated KCS and is particularly common in certain dog breeds, including Cocker Spaniels, Bulldogs, and West Highland White Terriers.
Other causes of KCS can include systemic diseases such as diabetes or hypothyroidism, certain medications that impair tear production, as well as mechanical damage or inflammatory conditions of the lacrimal glands. Infections, especially with canine adenovirus, can also contribute to the development of KCS.
Das Wichtigste auf einen Blick
Keratoconjunctivitis sicca (KCS), also known as dry eye syndrome, is a common eye condition in dogs caused by insufficient tear production. The main causes range from immune-related destruction of the lacrimal glands or medication side effects to systemic diseases such as diabetes or genetic factors. Symptoms include red eyes, increased blinking, a rough cornea, and reduced tear flow, which can lead to Pain and visual impairment. Diagnosis often uses the Schirmer tear test to measure tear production, supplemented by eye examinations to detect inflammatory conditions or corneal damage. Treatment aims to relieve symptoms and promote tear production, often with tear substitutes / artificial tears or immunosuppressive medications such as cyclosporine. In severe cases, a surgical procedure such as parotid duct transposition may be considered. Early diagnosis and therapy can significantly improve the quality of life of affected dogs. Prevention of KCS is challenging, especially when the cause is genetic or immune-mediated, but regular eye examinations and adjusted medication can help. Research focuses on improving diagnostics and therapy, including genetic studies and new drug approaches such as stem cell therapy, to further optimize treatment options for affected dogs.
Ursachen
- Immune-mediated destruction of the lacrimal glands.
- Side effects of certain medications.
- Systemic diseases such as diabetes mellitus or hypothyroidism.
- Genetic predisposition in certain breeds.
Symptoms
Symptoms of keratoconjunctivitis sicca in dogs can vary, but they are often characterized by signs of eye dryness and irritation. A common symptom is chronic inflammation and Conjunctival hyperemia, known as conjunctivitis. This may be accompanied by increased blinking or squinting as the animal tries to relieve the irritation.
Another common symptom is a thick, mucus-like discharge from the eyes. Because tear production is reduced, the eyes can no longer be cleaned effectively, leading to an accumulation of mucus and other secretions. This discharge is often yellow or greenish and can cause the eyelids to stick together.
Without treatment, KCS can lead to more serious complications, including corneal ulcers and Scar tissue formation. These changes can impair the dog’s vision and, in severe cases, lead to Blindness. Dogs with KCS often also show signs of discomfort or Pain, such as rubbing their eyes with their paws or on the ground.
Diagnose
The diagnosis of keratoconjunctivitis sicca is usually made through a combination of clinical findings and specific tests. A key test for diagnosing KCS is the Schirmer tear test. In this test, a special strip of filter paper is placed in the lower eyelid area to measure the amount of tear fluid produced. An abnormally low value indicates reduced tear production.
In addition to measuring tear production, the veterinarian can perform a thorough examination of the ocular surface to detect signs of inflammation, infection, or corneal damage. Fluorescein staining can be used to make corneal ulcers or injuries visible. This staining makes it possible to detect even the smallest corneal damage that might be missed during a simple visual inspection.
In some cases, a blood test may be necessary to rule out underlying systemic diseases such as autoimmune diseases or endocrine disorders that could contribute to the development of KCS. An accurate diagnosis is crucial to ensure appropriate therapy.
Therapie
Treatment of keratoconjunctivitis sicca aims to relieve symptoms, protect the ocular surface, and promote tear production. One of the most common treatment options is the use of tear substitutes / artificial tears, administered as eye drops or ointments. These products help moisturize the ocular surface and protect it from drying out.
In cases where an autoimmune disease is the cause of KCS, immunosuppressive medications such as cyclosporine or tacrolimus may be prescribed. These medications work by suppressing the immune response that attacks the lacrimal glands, thereby promoting tear production. Regular use of these medications can significantly improve symptoms and slow the progression of the disease.
In more severe cases, or when medical treatment is insufficient, surgery may be considered. One possible option is parotid duct transposition, in which a salivary gland duct is redirected to direct tear fluid into the eyes. However, this operation is complex and is usually only considered as a last resort.
Prognose und Nachsorge
The prognosis for dogs with keratoconjunctivitis sicca depends on the severity of the condition and the response to treatment. With early diagnosis and consistent therapy, the affected dogs’ quality of life can be significantly improved and the progression of the disease slowed. Many dogs respond well to treatment with tear substitutes / artificial tears and immunosuppressive medications and can live a largely normal life.
In some cases, especially if the condition is advanced or complications such as corneal ulcers or Scar tissue formation have occurred, the prognosis may be less favorable. Regular veterinary monitoring and adjustment of therapy are particularly important in such cases to achieve the best possible outcomes.
Prävention
Prevention of keratoconjunctivitis sicca is difficult in many cases, especially when the condition is genetic or immune-mediated. However, early detection and treatment of KCS can help slow the progression of the disease and prevent complications. Regular eye examinations, especially in dogs predisposed to developing KCS, are therefore important.
For dogs taking medications that may increase the risk of KCS, adjusting the medication or using tear substitutes / artificial tears as a preventive measure may be helpful. Good eye care, including regular cleaning of the eyes and surrounding area, can also help reduce the risk of infection and inflammatory conditions.
Overall, educating dog owners about the signs of KCS and the importance of early veterinary care is crucial to maintaining the health of their dog’s eyes. Close collaboration with the veterinarian can help develop the best preventive measures and treatment strategies for each individual dog.
Ausblick auf aktuelle Forschung
Keratoconjunctivitis sicca (KCS), also known as dry eye syndrome, is a common ophthalmic condition in dogs characterized by insufficient tear production. This condition can lead to inflammatory conditions and damage to the cornea and conjunctiva, which in the worst case can result in blindness. Current research focuses on improving diagnostic options and developing more effective treatment approaches to improve the quality of life of affected dogs.
A major advance in KCS research is the investigation of genetic factors that contribute to susceptibility to this condition. Scientists are trying to identify genetic markers associated with KCS to enable early detection and targeted prevention. In the future, this research could lead to genetic tests that allow breeders to minimize the risk of KCS in their breeding lines.
Another promising research approach is the development of new drug therapies. Various active substances are currently being tested that stimulate tear production or reduce inflammation of the ocular surface. Studies, including those with cyclosporine and tacrolimus—two immunosuppressive medications—show promising results in the therapy of KCS. These medications help increase tear production and relieve inflammation, effectively reducing the symptoms of the condition.
Stem cell therapy is another innovative approach being investigated in KCS research. Early studies suggest that stem cells have the potential to regenerate damaged tissue and restore tear production. Although this therapy is still in its early stages, it could become a groundbreaking treatment option in the future.
In addition to drug therapy, surgical solutions are also being researched. Procedures such as parotid duct transposition, in which saliva flow is used to moisten the eyes, are being further refined to increase success rates and minimize complications. Research focuses on making these techniques safer and more effective to help dogs with severe forms of KCS when other treatments fail.
Another important area of research is improving diagnostic procedures. Keratoconjunctivitis sicca is currently diagnosed mainly using the Schirmer tear test, which measures tear production. Researchers are working on more advanced diagnostic tools that enable more accurate and earlier detection. These could include biomarker tests or imaging procedures that analyze the condition of the ocular surface in greater detail.
The role of environmental factors in the development of KCS is also being intensively studied. There is evidence that air pollution, allergens, and other environmental stressors can worsen KCS symptoms. Research aims to better understand these factors and develop strategies to minimize their impact.
Research is also examining how diet and lifestyle can influence the risk and course of KCS. There is evidence that certain nutrients and dietary supplements can support eye health and relieve KCS symptoms. Omega-3 fatty acids and antioxidant vitamins are examples of substances currently being studied.
Finally, collaboration between veterinarians and eye researchers is crucial for progress in KCS treatment. The exchange of knowledge and data on a global level makes it possible to quickly integrate new findings into clinical practice and continuously improve the care of dogs with KCS.